
STABILITY AND CHARACTERIZATION
Our integrated research, formulation, product development, and manufacturing teams work closely together to anticipate challenges that hinder global accessibility and availability of critical immune-enhancing products.

PRODUCT DEVELOPMENT:
STABILITY STUDIES:

CHARACTERIZATION OF SMALL MOLECULES, MACROMOLECULE, AND VACCINE ADJUVANT FORMULATIONS
ANALYTICAL ASSAY DEVELOPMENT
Development of analytical assays to characterize the material of interest, including HPLC assays, ELISA, and other biophysical assays.
